9th IPF Summit
Join us in Boston this August, for the 9th IPF Summit - the only industry-focused summit dedicated to pulmonary fibrosis!
View the event guide here: https://ter.li/76agct
Why prioritize this summit?
As the only industry led meeting focused solely on pulmonary fibrosis this summit covers the entirety of the drug development pipeline, gathering pulmonary fibrosis experts from discovery through to clinical and outcomes all to reshape the future of pulmonary fibrosis therapeutics.
Capitalize on this strategic opportunity to connect with fellow drug development experts, to unite, troubleshoot and delve into the most pressing challenges and opportunities 2025 holds.
Here is an exclusive sneak peek of our world class speaker faculty:
- Carol Ann Satler, Vice President - Clinical Development, Insilico Medicine
- Cara Williams, Vice President, Pfizer
- Billy Fahy, Executive Director - Early, Clinical Research & Programs, Respiratory Lead, GSK
- Glenda Trujillo, Associate Director - Fibrosis Discovery Biology, Bristol Myers Squibb
- Elizabeth Estes, Executive Director, OSIC ILD
- Eric White, Senior Lead - Clinical Program & ILD, Boehringer Ingelheim
Special discounts for Fibrosis Journal members. Please register with code FIB10 to gain a 10% discount off on your registration fee. Register here: https://ter.li/3xogrc